InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Richardson Peter C, Directeur Médical. Director active across 1 companies, notably Antares Pharma, INC.. In total, 3 filings have been logged. The latest transaction was filed on 24 May 2022 — Disposition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€188,80836,199 shares@ €5.215841.8% of flow
Common Stock
SEC:0000899243-22-019794:0·
€131,44336,199 shares@ €3.6311100.0% of flow
Common Stock
SEC:0001209191-21-040338·
€131,44336,199 shares@ €3.631129.1% of flow
Common Stock
SEC:0001209191-21-040338:0·
3 of 3 declarations
About Richardson Peter C
Peter C. Richardson is Executive Vice President and Chief Medical Officer at Antares Pharma, Inc. He is responsible for leading research and medical development, ensuring innovation and effectiveness of the company's products.
